Hironobu SasanoMD, PhD, DABP
Professor Sasano has been involved in the translational research of various human neoplasms including adrenocortical disorders for nearly 30 years and has published more than 900 peer-reviewed articles including original, review and case reports. In particular, his groups have firstly established the details of in situ steroid biosynthesis and metabolism in human disorders, which resulted in the detailed endocrine-pathology correlation of various adrenocortical disorders as well as in establishment of intracrinology or intracrine estrogen production in human estrogen-dependent neoplasms such as breast cancer, also serving as the basis of aromatase inhibitor therapy currently employed as gold standard of endocrine therapy of hormone-dependent post-menopausal women with breast cancer.
He graduated from Tohoku University School of Medicine, Sendai, Japan in 1982 and his postgraduate training include clinical and research fellow in New York Hospital, The Cornel Medical Center, NY as a Fulbright Scholar and pathology resident at The George Washington University Medical Center and Armed Force Institute of Pathology, D.C. Professor Sasano is the board-certified pathologist in both Japan and U.S. and board-certified cytopathologists in Japan.